The data shown below were compiled from readership statistics for 79 Mendeley readers of this research output. Click here to see the associated Mendeley record.
| Title |
A randomized Phase II trial of the tumor vascular disrupting agent CA4P (fosbretabulin tromethamine) with carboplatin, paclitaxel, and bevacizumab in advanced nonsquamous non-small-cell lung cancer
|
|---|---|
| Published in |
OncoTargets and therapy, November 2016
|
| DOI | 10.2147/ott.s109186 |
| Pubmed ID | |
| Authors |
Edward B Garon, Jeffrey D Neidhart, Nashat Y Gabrail, Moacyr R de Oliveira, Jai Balkissoon, Fairooz Kabbinavar |
Mendeley readers
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 79 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 13 | 16% |
| Student > Bachelor | 8 | 10% |
| Researcher | 6 | 8% |
| Student > Ph. D. Student | 6 | 8% |
| Student > Doctoral Student | 3 | 4% |
| Other | 13 | 16% |
| Unknown | 30 | 38% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 14 | 18% |
| Nursing and Health Professions | 6 | 8% |
| Biochemistry, Genetics and Molecular Biology | 4 | 5% |
| Psychology | 3 | 4% |
| Chemistry | 3 | 4% |
| Other | 14 | 18% |
| Unknown | 35 | 44% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 March 2024.
All research outputs
#8,315,039
of 25,508,813 outputs
Outputs from OncoTargets and therapy
#494
of 3,021 outputs
Outputs of similar age
#114,971
of 318,134 outputs
Outputs of similar age from OncoTargets and therapy
#15
of 74 outputs
Altmetric has tracked 25,508,813 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 3,021 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 318,134 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 74 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.